A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease. For patients with localized PDAC, surgery is the best option, but with a median survival of less than 2 years and a difficult and prolonged postoperative course for most, there is an urgent need to better identify patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stratford, Jeran K., Bentrem, David J., Anderson, Judy M., Fan, Cheng, Volmar, Keith A., Marron, J. S., Routh, Elizabeth D., Caskey, Laura S., Samuel, Jonathan C., Der, Channing J., Thorne, Leigh B., Calvo, Benjamin F., Kim, Hong Jin, Talamonti, Mark S., Iacobuzio-Donahue, Christine A., Hollingsworth, Michael A., Perou, Charles M., Yeh, Jen Jen
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903589/
https://ncbi.nlm.nih.gov/pubmed/20644708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1000307
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars